bendamustine hydrochloride has been researched along with Mucositis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, HE; Albeirouti, B; AlJohani, NI; Alzahrani, Z; Nasani, M; Nawaz, A; Ur Rehman, J | 1 |
| Console, G; Gentile, M; Martino, M; Messina, G; Molica, S; Morabito, F; Recchia, AG; Tripepi, G; Vincelli, ID | 1 |
1 trial(s) available for bendamustine hydrochloride and Mucositis
| Article | Year |
|---|---|
A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Diarrhea; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Transplantation Conditioning; Treatment Outcome; Vomiting | 2016 |
1 other study(ies) available for bendamustine hydrochloride and Mucositis
| Article | Year |
|---|---|
Dose-adjusted bendamustine as a replacement for carmustine in autologous stem cell transplant conditioning for patients with relapsed lymphoma: A retrospective single-center study.
Topics: Bendamustine Hydrochloride; Cardiotoxicity; Carmustine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Mucositis; Retrospective Studies; Transplantation, Autologous | 2021 |